Identification of tp53 gene mutations in sporadic, familial breast cancer cases and Li.Fraumeni syndrome. Is codon 72 polymorphism of tp53 gene can be consider as an important mutation marker

被引：0
|
作者：
Aziz, I. [1 ]
Ali, S. [1 ]
Shakoori, A. R. [1 ]
机构：
[1] Univ Punjab, Sch Biol Sci, Lahore, Pakistan
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71569-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [1] CODON-72 POLYMORPHISM OF THE TP53 GENE
    ARA, S
    LEE, PSY
    HANSEN, MF
    SAYA, H
    NUCLEIC ACIDS RESEARCH, 1990, 18 (16) : 4961 - 4961
  • [2] Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer
    Foedermayr, Mathilde
    Sebesta, Miriam
    Rudas, Margaretha
    Berghoff, Anna S.
    Promberger, Regina
    Preusser, Matthias
    Dubsky, Peter
    Gnant, Michael
    Steger, Guenther G.
    Weltermann, Ansgar
    Zielinski, Christoph C.
    Zach, Otto
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 70 - 75
  • [3] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
  • [4] The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
    Langerod, A
    Bukholm, IRK
    Bregård, A
    Lonning, PE
    Andersen, TI
    Rognum, TO
    Meling, GI
    Lothe, RA
    Borresen-Dale, AL
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (12) : 1684 - 1688
  • [5] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
    Kyndi, M
    Alsner, J
    Hansen, LL
    Sorensen, FB
    Overgaard, J
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [6] Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene
    Gaëlle Bougeard
    Laurence Brugières
    Agnès Chompret
    Paul Gesta
    Françoise Charbonnier
    Alexander Valent
    Cosette Martin
    Grégory Raux
    Jean Feunteun
    Brigitte Bressac-de Paillerets
    Thierry Frébourg
    Oncogene, 2003, 22 : 840 - 846
  • [7] Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis
    Lattuada, D
    Viganò, P
    Somigliana, E
    Abbiati, A
    Candiani, M
    Di Blasio, AM
    MOLECULAR HUMAN REPRODUCTION, 2004, 10 (09) : 651 - 654
  • [8] Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer
    Lopes, Leandra Fiori
    Guembarovski, Roberta Losi
    Guembarovski, Alda Losi
    Kishima, Marina Okuyama
    Campos, Clodoaldo Zago
    Derossi, Daniela Rudgeri
    Ariza, Carolina Batista
    Murobushi Ozawa, Patricia Midori
    Coral de Oliveira, Carlos Eduardo
    Banin-Hirata, Bruna Karina
    Freire Vitiello, Glauco Akelinghton
    Borelli, Sueli Donizete
    Ehara Watanabe, Maria Angelica
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2014, 57 (06) : 895 - 899
  • [9] TP53 Codon 72 Polymorphism and Breast Cancer in Northern Iran
    Kazemi, Masood
    Salehi, Zivar
    Chakosari, Roohi Jamal
    ONCOLOGY RESEARCH, 2009, 18 (01) : 25 - 30
  • [10] TP53 CODON 72 POLYMORPHISM AND MICROSATELLITE INSTABILITY IN SPORADIC COLORECTAL CANCER
    Dastjerdi, Mehdi Nikbahkt
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3253 - 3253
12345